Le Lézard
Classified in: Health, Covid-19 virus
Subjects: SVY, FVT

Medical expert warns thousands could die from HPV programming interrupted by Covid-19


LONDON, March 3, 2021 /CNW/ -- On HPV Awareness Day, the International Papillomavirus Society is urging women to attend delayed cervical screenings and for all interrupted services to re-start as thousands continue to miss out on vital HPV care, with deadly consequences. The IPVS is also calling for global vaccine equity.

One woman dies from cervical cancer every 2 minutes but HPV is a virus that can be beaten, if services are rolled out and taken up. In higher income countries, cervical screenings have reduced from 70% to 30-40% and 32% of women are unlikely to attend appointments due to Covid-19 fears.

IPVS calls for everyone to 'Ask About HPV' ? speak to local politicians, healthcare practitioners and seek information at www.askabouthpv.org.

86% of cervical cancers occur in developing countries where the story is even more serious. In sub-Saharan Africa, with the highest rate of cervical cancer in the world, cervical screening is available to less than 5% of eligible women.

Professor Margaret Stanley, President of IPVS, says "It's unfathomable that there is such inequality in the roll-out of crucial, inexpensive medical care. Young women are missing vital appointments now which could be fatal. More than 350,000 people die annually from HPV-related illnesses. Early prevention and treatment is key? the world needs to step up."

IPVS is hosting a high -level panel featuring WHO'S Dr Princess Notembe Simelela amongst other distinguished speakers at 3pm GMT on 4th March to define how we can accelerate progress against HPV in the era of Covid-19, which the public and media are welcome to attend.

Approximately 20% of men have HPV DNA detected in their genital area, and cases are increasing every year, leading to deaths from anal, penile and throat cancers. Screening and treatment to prevent these cancers is not widely available.

Dr Joel Palefsky, HPV Awareness Campaign Chair and expert on HPV-related cancer in men, said, "Quite rightly the focus has been on cervical cancer, the leading cause of death in women from HPV-related cancer. However, anal and throat cancers are becoming increasingly common, and men with HIV or immune suppression are particularly high risk. We need to dispel the stigma."

Notes to Editors

Sources: Professor Gordon Wishart, Chief Medical Officer,Check4Cancer Check4cancer.com, Eliminating cervical cancer in the COVID-19 era | Nature Cancer Delayed Cancer Screenings?A Second Look (ehrn.org)

SOURCE International Papillomavirus Society


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: